| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 10 |
| 1 | VEDOLIZUMAB | 7 |
| 2 | CANDESARTAN CILEXETIL | 6 |
| 3 | CARVEDILOL | 6 |
| 4 | DARBEPOETIN ALFA | 6 |
| 5 | DOXAZOSIN MESYLATE | 6 |
| 6 | FLUVASTATIN | 6 |
| 7 | FUROSEMIDE | 6 |
| 8 | INFLIXIMAB-DYYB | 6 |
| 9 | MINOXIDIL | 6 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 6 | 0.0017 |
| 1 | ADALIMUMAB-AFZB | 2 | 0.0007 |
| 2 | FINGOLIMOD HYDROCHLORIDE | 3 | 0.0006 |
| 3 | SIPONIMOD | 4 | 0.0004 |
| 4 | AZATHIOPRINE SODIUM | 1 | 0.0004 |
| 5 | AMPHOTERICIN B | 5 | 0.0004 |
| 6 | VALGANCICLOVIR | 6 | 0.0003 |
| 7 | FLUOROMETHOLONE | 1 | 0.0003 |
| 8 | TAMSULOSIN HYDROCHLORIDE | 6 | 0.0003 |
| 9 | SODIUM BICARBONATE INJECTION, | 6 | 0.0003 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 1 | Sphingosine 1-phosphate Receptor Modulator [EPC] | 4 | 0.0003 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 6 | 0.0003 |
| 3 | Polyene Antifungal [EPC] | 5 | 0.0001 |
| 4 | Erythropoiesis-stimulating Agent [EPC] | 6 | 0.0001 |
| 5 | Provitamin D2 Compound [EPC] | 3 | 0.0001 |
| 6 | Integrin Receptor Antagonist [EPC] | 8 | 0.0001 |
| 7 | Arteriolar Vasodilator [EPC] | 6 | 0.0001 |
| 8 | 5-alpha Reductase Inhibitor [EPC] | 6 | 0.0001 |
| 9 | Purine Antimetabolite [EPC] | 5 | 0.0001 |